Home Article ResMed named finalist

ResMed named finalist

ResMed named finalist

Also Noted

Default Author Head Shot

By HME News Staff

Updated Wed December 6, 2017

SAN DIEGO - ResMed has been named a finalist for “Medtech Company of the Year” by MD+DI, a news resource in the medical device and diagnostic industry. Among ResMed's accomplishments, MD+DI highlighted its milestone of capturing 1 billion nights of monitored sleep apnea therapy and a CHEST-published study showing its self-monitoring app myAir can help boost therapy adherence to 87%. “ResMed has made strides this year in encouraging patient adherence with treatment and easing their ability to track progress,” MD+DI stated in its announcement. MD+DI will announce the “Medtech Company of the Year” on Dec. 11. Other finalists include Abbott, Baxter, Bigfoot Biomedical and Pentax Medical.

Comments

To comment on this post, please log in to your account or set up an account now.